Michaela Feuring‐Buske

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 666 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Measurable Residual Disease +16

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Peter Borchmann, Helen Goergen, Carsten Kobe et al. · The Lancet · 2017 · 372 citations

Positron Emission Tomography, Advanced-stage Hodgkin, Lymphoid Neoplasia +9

Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications

Sabyasachi Chakrabortty, Bikram Keshari Agrawalla, Anne Stumper et al. · Journal of the American Chemical Society · 2017 · 309 citations · Full text

Organelle-targeted Photosensitization, Nanomedicine, Protein-ruthenium Photosensitizer +12

The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice

Christina Schessl, Vijay P.S. Rawat, Monica Cusan et al. · Journal of Clinical Investigation · 2005 · 240 citations · Full text

Hematological Malignancy, Systems Biology, Signal Transduction +13

Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations

D. Haase, Michaela Feuring‐Buske, Stephanie Könemann et al. · Blood · 1995 · 152 citations · Full text